Condition (MeSH)
Cri-du-Chat Syndrome
ClinicalTrials.gov lists 3 trials for Cri-du-Chat Syndrome or a narrower condition beneath it. Natera, Inc. has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
3 of the 3 trials are tagged with Cri-du-Chat Syndrome itself; the rest are tagged with a narrower condition beneath it.
When did Cri-du-Chat Syndrome trials start? (3)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Not applicable
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 1 |
| 2015 | 1 |
| 2010 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Cri-du-Chat Syndrome trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Not applicable | 1 |
| Observational | 2 |
How many Cri-du-Chat Syndrome trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 2 |
| Completed | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Cri-du-Chat Syndrome trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Natera, Inc. | 1 |
Which publications cover Cri-du-Chat Syndrome? (1)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: proceed with caution. | Obstetrics and gynecology | 2014 | No |
Prevalence (9)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Monosomy 5p syndrome | Prevalence at birth | 1-9 / 100 000 | Japan | Not stated | Exact |
| Monosomy 5p syndrome | Prevalence at birth | 1-9 / 100 000 | Denmark | Not stated | Unspecified |
| Monosomy 5p syndrome | Prevalence at birth | 1-9 / 100 000 | Japan | Not stated | Unspecified |
| Monosomy 5p syndrome | Prevalence at birth | 1-9 / 100 000 | Japan | Not stated | Exact |
| Monosomy 5p syndrome | Point prevalence | Unknown | Worldwide | Not stated | Exact |
Showing 5 of 9 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Monosomy 5p syndrome | 281 | Exact | Orphadata Science knowledge files, Product 1 |
| Monosomy 5p syndrome | 281 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.